Dual antiplatelet management in the perioperative period: updated and expanded systematic review.

ABSTRACT:

Background

Antiplatelet agents are central in the management of vascular disease. The use of dual antiplatelet therapy (DAPT) for the management of thromboembolic complications must be weighed against bleeding risk in the perioperative setting. This balance is critical in patients undergoing cardiac or non-cardiac surgery. The management of patients on DAPT for any indication (including stents) is not clear and there is limited evidence to guide decision-making. This review summarizes current evidence since 2015 regarding the occurrence of major adverse events associated with continuing, suspending, or varying DAPT in the perioperative period.

Methods

A research librarian searched PubMed and Cochrane from November 30, 2015 to May 17, 2022, for relevant terms regarding adult

SUBMITTER: Premji AM 

PROVIDER: S-EPMC10576385 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature